Prostate cancer cells survive anti‐androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities-Reference-Cited by-同舟云学术

Prostate cancer cells survive anti‐androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities

Published:2021-06-25 Issue:12 Volume:81 Page:799-811
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Basu Hirak S.¹^ORCID,Wilganowski Nathaniel¹,Robertson Samantha¹,Reuben James M.²,Cohen Evan N.²,Zurita Amado¹,Ramachandran Sumankalai¹,Xiao Lian‐Chun³,Titus Mark¹,Wilding George¹

Affiliation:

1. Department of Genitourinary Oncology, MD Anderson Cancer Center University of Texas Houston Texas USA

2. Department of Hematopathology, MD Anderson Cancer Center University of Texas Houston Texas USA

3. Department of Biostatistics University of Texas, MD Anderson Cancer Center Houston Texas USA

Funder

Congressionally Directed Medical Research Programs

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24146

Reference26 articles.

1. Prostate Cancer: Quo Vadis?

2. Distinguishing Indolent from Aggressive Prostate Cancer

3. Understanding the Warburg effect: the metabolic requirements of cell proliferation;Vander Heiden MG;Science

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer;Endocrinology;2024-08-27

2. The polyunsaturated fatty acid docosahexaenoic affects mitochondrial function in prostate cancer cells;Cancer & Metabolism;2024-08-07

3. Identification of prostate cancer bone metastasis related genes and potential therapy targets by bioinformatics and in vitro experiments;Journal of Cellular and Molecular Medicine;2024-08

4. Tracking down metabolic vulnerabilities in CDK12‐mutant prostate cancer;Clinical and Translational Discovery;2024-07-19

5. Enzalutamide Sensitizes Castration‐Resistant Prostate Cancer to Copper‐Mediated Cell Death;Advanced Science;2024-06-10